Perception and clinical practice regarding mucus clearance devices with chronic obstructive pulmonary disease: a cross-sectional study of healthcare providers in Saudi Arabia.

Autor:	Alghamdi SM; Department of Clinical Technology, Respiratory Care Program, Umm Al-Qura University, Makkah, Saudi Arabia smghamdi@uqu.edu.sa., Alzahrani A; Department of Clinical Technology, Respiratory Care Program, Umm Al-Qura University, Makkah, Saudi Arabia., Alshahrani YM; Department of Clinical Technology, Emergency Medical Services Program, Umm Al-Qura University, Makkah, Saudi Arabia., Al Ruwaithi AA; Department of Clinical Technology, Emergency Medical Services Program, Umm Al-Qura University, Makkah, Saudi Arabia., Aldhahir AM; Department of Respiratory Therapy, Jazan University, Jazan, Saudi Arabia., Alsulayyim AS; Department of Respiratory Therapy, Jazan University, Jazan, Saudi Arabia., Siraj RA; Department of Respiratory Therapy, King Faisal University, Al-Hasa, Saudi Arabia., Almansour AH; Department of Family Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Alasmari AM; Department of Respiratory Therapy, College of Medical Rehabilitation Services, Taibah University, Madinah, Saudi Arabia., Alqahtani JS; Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia., Alanazi AM; Department of Respiratory Care, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Jaishi ST; Al-Noor Specialist Hospital, Saudi Arabia Ministry of Health, Makkah, Saudi Arabia., Allehyani BA; King Abdullah Medical City, Makkah, Saudi Arabia., Hopkinson NS; National Heart and Lung Insititute, Imperial College London, London, UK.
Jazyk:	angličtina
Zdroj:	BMJ open [BMJ Open] 2023 Sep 14; Vol. 13 (9), pp. e074849. Date of Electronic Publication: 2023 Sep 14.
DOI:	10.1136/bmjopen-2023-074849
Abstrakt:	Objectives: Clearing secretions from the airway can be difficult for people with chronic obstructive pulmonary disease (COPD). Mucus clearance devices (MCDs) are an option in disease management to help with this, but healthcare provider awareness and knowledge about them as well as current clinical practice in Saudi Arabia are not known. Design: A cross-sectional online survey consisting of four themes; demographics, awareness, recommendations and clinical practice, for MCDs with COPD patients. Setting: Saudi Arabia. Participants: 1188 healthcare providers including general practitioners, family physicians, pulmonologists, nursing staff, respiratory therapists and physiotherapists. Primary Outcome Measures: Healthcare providers' level of awareness about MCDs, and the identification of current clinical practices of COPD care in Saudi Arabia. Results: 1188 healthcare providers (44.4% female) completed the survey. Regarding devices, 54.2% were aware of the Flutter, 23.8% the Acapella and 5.4% the positive expiratory pressure mask. 40.7% of the respondents identified the Acapella, and 22.3% the Flutter as first choice for COPD management. 75% would usually or always consider their use in COPD patients reporting daily difficulty clearing mucus, whereas 55.9% would sometimes or usually consider the use of MCDs with COPD patients who produced and were able to clear mucus with cough. In clinical practice, 380 (32%) of the respondents would prescribe MCDs, 378 (31.8%) would give MCDs without prescriptions, 314 (26.4%) would not provide them at all and 116 (9.8%) would only advise patients about them. Conclusion: Healthcare providers are aware of the existence of MCDs and their benefits for sputum clearance and believe that MCDs are beneficial for sputum clearance in some COPD patients. Trial Registration Number: ISRCTN44651852. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu